Plasma-Lyte 148 & Glucose 5% infusion 1litre Viaflo bags

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktīvā sastāvdaļa:

Glucose monohydrate; Sodium chloride; Sodium gluconate; Potassium chloride; Sodium acetate trihydrate; Magnesium chloride hexahydrate

Pieejams no:

Baxter Healthcare Ltd

ATĶ kods:

B05BB02

SNN (starptautisko nepatentēto nosaukumu):

Glucose monohydrate; Sodium chloride; Sodium gluconate; Potassium chloride; Sodium acetate trihydrate; Magnesium chloride hexahydrate

Deva:

55gram/1litre ; 5.26gram/1litre ; 5.02gram/1litre ; 370mg/1litre ; 3.68gram/1litre ; 300mg/1litre

Zāļu forma:

Infusion

Ievadīšanas:

Intravenous

Klase:

No Controlled Drug Status

Receptes veids:

Never Valid To Prescribe As A VMP

Produktu pārskats:

BNF: 09030000; GTIN: 55413760266720

Produkta apraksts

OBJECT 1
PLASMA-LYTE 148 & GLUCOSE 5% W/V SOLUTION FOR
INFUSION
Summary of Product Characteristics Updated 05-Apr-2018 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Plasma-Lyte 148 & Glucose 5% w/v solution for infusion.
2. Qualitative and quantitative composition
Glucose monohydrate
55.00 g/l
Sodium Chloride:
5.26 g/l
Potassium Chloride:
0.37 g/l
Magnesium Chloride hexahydrate:
0.30 g/l
Sodium Acetate trihydrate:
3.68 g/l
Sodium Gluconate:
5.02 g/l
Na
+
K
+
Mg
++
Cl
-
CH
3
COO
-
C
6
H
11
O
7
-
(Acetate)
(Gluconate
)
mmol/l
140
5.0
1.5
98
27
23
mEq/l
140
5.0
3.0
98
27
23
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for infusion.
Clear solution, free from visible particles
Osmolarity: 572 mOsm/l (approx.)
pH: 4.0 to 6.0
4. Clinical particulars
4.1 Therapeutic indications
Plasma-Lyte 148 & Glucose 5% w/v is indicated:
- for fluid replacement with carbohydrate supply (e.g. after burns,
head injury, fracture, infection, and
peritoneal irritation),
- as intraoperative fluid replacement,
- in mild to moderate metabolic acidosis, also in case of lactate
metabolism impairment.
4.2 Posology and method of administration
Adults, the Elderly, Adolescents and Children:
The dosage and rate of administration depend on the age, weight,
clinical and biological conditions of the
patient and concomitant therapy.
Fluid balance, blood glucose, and serum electrolytes should be
monitored before and during
administration (see sections 4.4, 4.5, 4.6 and 4.8).
_Recommended dosage_:
The recommended dosage is:
- for adults, the elderly and adolescents: 500 ml to 3 litres / 24h
- for infants, toddlers and children:
- 0-10 kg body weight : 100 ml/kg/24h
- 10-20 kg body weight : 1000 ml + (50 ml /kg over 10 kg) /24h
- > 20 kg body weight : 1500 ml + (20 ml/kg over 20 kg)/24h
_Administration rate:_The infusion rate is usually 40 mL/kg/24h in
adults, the elderly and adolescents.
When used for intraoperative fluid replacement, normal rate can be
higher and is about 15 mL/kg/h.
In paediatric patients t